Ferrari Mauro's Form 4 filing
Arrowhead Pharmaceuticals, Inc. (ARWR) · filed Jan 16, 2024
- Accession no.
- 0001628280-24-001423
- Filed
- Jan 16, 2024
- Trade date
- Jan 11, 2024
- Filing delay
- 5 days
- Rule 10b5-1 plan
- Checked
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market sales total $119.8K. It was filed 5 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Ferrari MauroCIK 0001506045 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 11, 2024 | Common Stock | SSaleDisposed | −2,147 | $37.80 | −$81,156.6 | 61,778 | Direct | |
| Jan 11, 2024 | Common Stock | SSaleDisposed | −1,000 | $38.63 | −$38,630 | 60,778 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.